Recent advances in targeted therapies in acute myeloid leukemia

Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic stem cell transplantation (alloHSCT), this effect has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhansali, Rahul S., Pratz, Keith W., Lai, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039574/
https://www.ncbi.nlm.nih.gov/pubmed/36966300
http://dx.doi.org/10.1186/s13045-023-01424-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039574/
https://www.ncbi.nlm.nih.gov/pubmed/36966300
http://dx.doi.org/10.1186/s13045-023-01424-6

Ejemplares similares